 0 Table of Contents |
  1 Home |
  2 Examples |
  3 Artifacts Summary |
   3.1 EMA Write API ActivityDefinition |
   3.2 EMA Write API Marketing Regulated Authorization |
   3.3 EMA Write API MedicinalProductDefinition |
   3.4 EMA Write API PackagedProductDefinition |
   3.5 EMA Write PMS API Bundle |
   3.6 EMA AdditionalMonitoringIndicator boolean CodeableConcept |
   3.7 EMA Application Identifier Number |
   3.8 EMA ATC Coding |
   3.9 EMA Coding |
   3.10 EMA Coding Restrictions |
   3.11 EMA Data Carrier Identifier |
   3.12 EMA Duration |
   3.13 EMA EURD Identifier |
   3.14 EMA Generic ReferentialTerm CodeableConcept |
   3.15 EMA Generic ReferentialTerm CodeableConcept restrictions |
   3.16 EMA Genetically Modified Organisms CodeableConcept |
   3.17 EMA Identifier Restrictions |
   3.18 EMA Identifier Restrictions |
   3.19 EMA Legal Basis CodeableConcept |
   3.20 EMA Light ATC CodeableConcept |
   3.21 EMA Manufacturing Authorization Number Identifier |
   3.22 EMA Marketing Authorization Identifier |
   3.23 EMA Master File Identifier |
   3.24 EMA MP Identifier |
   3.25 EMA PC Identifier |
   3.26 EMA Period |
   3.27 EMA Period restrictions |
   3.28 EMA Product Category CodeableConcept |
   3.29 EMA Qualified Person Type CodeableConcept |
   3.30 EMA Quantity |
   3.31 EMA Ratio |
   3.32 EMA Subject Restrictions |
   3.33 EMA Subject Restrictions |
   3.34 EMA XEVMPD Product CodeableConcept |
   3.35 The MPD Name Part Type Coding |
   3.36 Authorised Dose Form |
   3.37 CodeSystemName |
   3.38 Date of Update extension |
   3.39 Language |
   3.40 Marketing Status Reason |
   3.41 MedicinalProductDefiniton - MasterFile |
   3.42 Regulated Authorization - Date of First Authorisation |
   3.43 Regulated Authorization - International Birth Date |
   3.44 Regulated Authorization - Paediatric - Reference Country |
   3.45 Risk of Supply Shortage |
   3.46 Risk of Supply Shortage Comment |
   3.47 Submission Date extension |
   3.48 TermVersion |
   3.49 The ATC Pending Extension |
   3.50 The Comparator Extension |
   3.51 The Complies with directive Extension |
   3.52 The Ingredient Annex 5.10 Extension |
   3.53 The Ingredient Annex 5.11 Extension |
   3.54 The Ingredient Annex 5.20 Extension |
   3.55 The Ingredient Annex 5.23 Extension |
   3.56 The Ingredient Documentation Extension |
   3.57 The Ingredient's Origin of Substance Extension |
   3.58 The Operation Extension |
   3.59 The Package Shelf Life Duration Extension |
   3.60 Additional Monitoring Indicator |
   3.61 Application Submission Type |
   3.62 Authorised Dose Form |
   3.63 Combined Pharmaceutical Dose Form |
   3.64 Country |
   3.65 Data Classification |
   3.66 Documentation |
   3.67 Domain |
   3.68 Genetically Modified Organism |
   3.69 Ingredient Role |
   3.70 Language |
   3.71 Legal Status of Supply |
   3.72 Manufacturing Activity |
   3.73 Marketing and Manufacturing types |
   3.74 Marketing Status |
   3.75 Marketing Status Reason |
   3.76 Master File Identifier Type |
   3.77 Master File Type |
   3.78 Master File Type + DocumentType |
   3.79 Material |
   3.80 Medicinal Product Name Part Type |
   3.81 Medicinal Product Type |
   3.82 Packaging |
   3.83 Paediatric Use Indicator |
   3.84 Pharmaceutical Dose Form |
   3.85 Product Category |
   3.86 Product Cross Reference Type |
   3.87 Promotion |
   3.88 Quantity Operator |
   3.89 Regulatory Authorization Registration Procedure |
   3.90 Regulatory Entitlement Status |
   3.91 Regulatory Entitlement Type |
   3.92 Shelf Life Type |
   3.93 Special Precautions For Storage |
   3.94 Substance Origin |
   3.95 Supply |
   3.96 Unit of Measurement |
   3.97 Units of Presentation |
   3.98 XEVMPD medicinal product type |
   3.99 XEVMPD medicinal product type |
   3.100 Additional Monitoring Indicator |
   3.101 Application Submission Type |
   3.102 Combination Package |
   3.103 Combined Pharmaceutical Dose Form |
   3.104 Combined Term |
   3.105 Contact Type |
   3.106 Country |
   3.107 Data Classification |
   3.108 Document Type |
   3.109 Documentation |
   3.110 Domain |
   3.111 Domain |
   3.112 Domain |
   3.113 Genetically Modified Organism |
   3.114 Ingredient Role |
   3.115 Legal Status From the Supply |
   3.116 Manufacturing Activity Value Set |
   3.117 Marketing Authorisation Application Legal Basis |
   3.118 Marketing Status |
   3.119 Master File Identifier Type |
   3.120 Master File Type |
   3.121 Material |
   3.122 Medicinal Product Name Part Type |
   3.123 Medicinal Product Type |
   3.124 Paediatric Use Indicator |
   3.125 Pharmaceutical Dose Form |
   3.126 Product Category |
   3.127 Product Cross Reference Type |
   3.128 Promotion |
   3.129 Quantity Operator |
   3.130 Reason for Marketing Unavailability |
   3.131 Record Status |
   3.132 Regulatory Authorization Registration Procedure |
   3.133 Regulatory Entitlement |
   3.134 Regulatory Entitlement Status |
   3.135 Shelf Life Type |
   3.136 Special Precautions for Storage |
   3.137 Substance Origin |
   3.138 Supply |
   3.139 Unit Of Measurement Value Set |
   3.140 Units Of Presentation |
   3.141 XEVMPD Medicinal Product Type |
   3.142 1. Get Product Bundle |
   3.143 2. Change pack size |
   3.144 3. Change pack size (response) |
   3.145 4. Add manufacturing operation |
   3.146 5. Add manufacturing operation (response) |
   3.147 ActivityDefinition |
   3.148 DocumentReference |
   3.149 DocumentReference |
   3.150 Organization |
   3.151 PractitionerRole |